Wolverine Trading’s Acceleron Pharma XLRN Stock Holding History

Wolverine Trading’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,700	Closed	-$461K	–	7350
2021 Q2	$461K	Buy	3,700 +1,200	+48%	+$151K	﹤0.01%	3824
2021 Q1	$333K	Sell	2,500 -1,400	-36%	-$181K	﹤0.01%	4326
2020 Q4	$498K	Sell	3,900 -5,000	-56%	-$586K	﹤0.01%	3182
2020 Q3	$1.01M	Sell	8,900 -2,000	-18%	-$199K	﹤0.01%	2081
2020 Q2	$1.05M	Buy	+10,900	New	+$1.05M	﹤0.01%	1963
2020 Q1	–	Sell	-4,100	Closed	-$216K	–	5584
2019 Q4	$216K	Sell	4,100 -2,100	-34%	-$95.8K	﹤0.01%	3940
2019 Q3	$251K	Sell	6,200 -5,600	-47%	-$243K	﹤0.01%	3343
2019 Q2	$485K	Sell	11,800 -3,700	-24%	-$153K	﹤0.01%	2755
2019 Q1	$722K	Buy	+15,500	New	+$681K	﹤0.01%	2393
2018 Q4	–	Sell	-8,800	Closed	-$504K	–	5673
2018 Q3	$504K	Buy	+8,800	New	+$432K	﹤0.01%	3106

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Wolverine Trading's XLRN Position: Q3 2021 in Review

Wolverine Trading sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 1,606 shares — an estimated $200K sold.

Wolverine Trading first reported a position in XLRN in Q3 2018 and held it in 3 quarters. The position peaked at $1.02M in Q3 2018. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

Wolverine Trading reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
Wolverine Trading sold 1,606 Acceleron Pharma shares in Q3 2021, an estimated $200K.
Wolverine Trading first reported a position in Acceleron Pharma in Q3 2018 and held it in 3 quarters.
Wolverine Trading's Acceleron Pharma position peaked at $1.02M in Q3 2018.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.